Springer Nature
Browse
12931_2017_583_MOESM1_ESM.docx (288.3 kB)

Additional file 1: of Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

Download (288.3 kB)
journal contribution
posted on 2017-05-30, 05:00 authored by Dave Singh, Anthony D’Urzo, Ferran Chuecos, Anna Muñoz, Esther Garcia Gil
Sensitivity analysis of the risk of CID events for common visits, characterization of patients according to CID endpoints achieved and analysis of the risk of CID events over 24 weeks, stratified by ICS use, previous treatment, and symptoms. (DOCX 289 kb)

Funding

Almirall S.A.

History